Die gesamte Produktionskapazität liegt derzeit bei zwei Milliarden Dosen. For Media contacts, click here. Wenn Sie sich über unsere die Aktionsfelder in anderen Ländern informieren möchten, klicken Sie auf den Link „Standorte weltweit“. Der rekombinante Adenovirus-Vektor (ChAdOx1) wurde gewählt, um eine starke Immunantwort auf eine Einzeldosis zu erzeugen. Data from the DESTINY programme will highlight the transformative potential of Enhertu (trastuzumab deruxtecan) across HER2-driven tumours, including in lung, breast, gastric and colorectal cancers.
Our Press Release archive contains all of our press releases dated before 2018 so you should be able to find just what you are looking for. Mit der heutigen Vereinbarung zielt die IVA darauf ab, die Lieferung des Impfstoffs zu beschleunigen und ihn anderen europäischen Ländern, die sich an der Initiative beteiligen möchten, zur Verfügung zu stellen. > Press Releases > Daiichi Sankyo and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062; For Immediate Release. Your email address will only be used to provide you with services from AstraZeneca that you requested. Please refer to your approved national product label (SmPC) for current product information. B. Fieber, grippeähnliche Symptome, Kopfschmerzen und Armprobleme hervorrufen kann. Cliquez sur «Sites des autres pays» pour accéder à la liste de l’ensemble des sites. Finanzielle Erwägungen Die AstraZeneca GmbH ist die deutsche Tochtergesellschaft des britisch-schwedischen Pharmaunternehmens AstraZeneca PLC. For details on how to contact the Investor Relations Team, please click here. Sie haben einen Link ausgewählt, der Sie auf eine nicht von AstraZeneca betriebene Webseite führt. Für Einzelheiten zur Kontaktaufnahme mit dem Investor Relations Team klicken Sie bitte hier. Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed. Les pages liées possèdent leurs propres conditions d’utilisation et peuvent être soumises à d’autres législations ou standards. About this site. Our country sites can be located in the AZ Network. Important notice for users Sunday 31 May, 1:00pm EDT, Phase II study of savolitinib in patients with pulmonary sarcomatoid carcinoma and other types of NSCLC harboring MET exon 14 skipping mutations, Poster Discussion - Lung Cancer - Non-Small Cell Metastatic, SAVOIR: A Phase III study of savolitinib vs. sunitinib in patients with MET-driven papillary renal cell carcinoma, Oral Abstract Session - Genitourinary Cancer - Kidney and Bladder, Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated NSCLC, Oral Abstract Session - Lung Cancer- Non-Small Cell Metastatic, ECOG-ACRIN 5162: A Phase II study of osimertinib 160 mg in NSCLC with EGFR exon 20 insertions, A Phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive, HER2-negative advanced breast cancer (SERENA-1), Poster Discussion - Breast Cancer - Metastatic, A Phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (CAPItello290), Acalabrutinib vs Idelalisib plus Rituximab or Bendamustine plus Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia: ASCEND Final Results, Poster Discussion - Hematologic Malignancies - Lymphoma and Chronic Lymphocytic Leukemia, Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia: Mature Results From Phase II Study Demonstrating Durable Remissions and Long-Term Tolerability, Poster Session - Hematologic Malignancies - Lymphoma and Chronic Lymphocytic Leukemia, Safety of Acalabrutinib Monotherapy in Hematologic Malignancies: Pooled Analysis From Clinical Trials, Trastuzumab deruxtecan in patients with HER2-mutated metastatic NSCLC: Interim results of DESTINY-Lung01, Trastuzumab deruxtecan in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma: A randomized, Phase II, multicenter, open-label study (DESTINY-Gastric01), Poster Session - Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary, A Phase II, multicenter, open-label study of trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer: DESTINY-CRC01, Oral Abstract Session - Gastrointestinal Cancer - Colorectal and Anal, Trastuzumab deruxtecan for HER2-positive metastatic breast cancer: DESTINY-Breast01 subgroup analysis, Poster Session - Breast Cancer- Metastatic.
You are about to access AstraZeneca historic archive material. Advancing treatment in other cancer types with high unmet need. Partnering with AstraZeneca Our Partnering teams Our areas of partnering interest Why partner with AstraZeneca? Für Medienkontakte klicken Sie bitte hier. Latest press releases. This website is intended for people seeking information on AstraZeneca's worldwide business. Press Releases. I have read this warning and will not be using any of the contained product information for clinical purposes. For media information about our Global operation please visit our global website. April 2020. Press releases This website is intended for people seeking information on AstraZeneca's Australia business. By harnessing the power of four scientific platforms - Immuno-Oncology, Tumour Drivers and Resistance, DNA Damage Response and Antibody Drug Conjugates - and by championing the development of personalised combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death.
Sie haben einen Link ausgewählt, der Sie auf eine nicht von AstraZeneca betriebene Webseite führt. Kontakt Press Releases Media centre Articles Image library Broadcast videos Archive Media contacts Sustainability. Diese Website bietet eine Übersicht über die Geschäftsaktivitäten von AstraZeneca Deutschland. We look f… https://t.co/A6TnMulTc8, #COVID19 has delayed #breastcancer screening programmes, early detection & management.
Ziel ist es, in den nächsten drei bis fünf Monaten klinische Studien durchzuführen. Sustainability Access to healthcare Environmental protection Ethics and transparency Resources Partnering . You are about to access AstraZeneca historic archive material. Additionally, subgroup analyses from the Phase II DESTINY-Breast01 trial will reinforce the durable and consistent responses seen with Enhertu in HER2-positive metastatic breast cancer. Die Universität Oxford gab im vergangenen Monat den Beginn einer britischen Phase-II/III-Studie mit AZD1222 an etwa 10.000 erwachsenen Freiwilligen bekannt. AstraZeneca will present ground-breaking new results across its broad portfolio of cancer medicines during the 2020 American Society of Clinical Oncology ASCO20 Virtual Scientific Program, 29 to 31 May 2020. Your email address will only be used to provide you with services from AstraZeneca that you requested. Beyond ADAURA, an oral presentation of the final analysis of the Phase III CASPIAN trial confirms the sustained, clinically meaningful overall survival (OS) benefit of Imfinzi for patients with extensive-stage small cell lung cancer (ES-SCLC). Enhertu was recently granted Breakthrough Therapy Designation in the US for patients in this setting. Latest. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. AstraZeneca gehört mit einem Konzernumsatz von rund 24,4 Milliarden USD (2019) weltweit zu den führenden Unternehmen der forschenden Arzneimittelindustrie. Important notice for users We encourage you to read the privacy policy of every website you visit. AstraZeneca will present data from several trials highlighting how the Company’s leading research is progressing treatment in other cancers where a high unmet medical need remains, including: Durvalumab ± tremelimumab + platinum-etoposide in first-line ES-SCLC: Results from the Phase III CASPIAN study, Oral Abstract Session - Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers, First-line durvalumab plus platinum-etoposide in ES-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes, Poster Session - Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers, Non-pneumonitis immune-mediated adverse events with durvalumab in patients with unresectable, Stage III NSCLC (PACIFIC), Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab in combination with durvalumab for patients with advanced hepatocellular carcinoma (Study 22), Oral Abstract Session - Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary, Phase II study assessing tolerability, efficacy and biomarkers for durvalumab ± tremelimumab and gemcitabine/cisplatin in chemo-naïve advanced biliary tract cancer, Poster Session - Gastrointestinal Cancer: Gastroesophageal, Pancreatic, and Hepatobiliary, A Phase I, open-label multi-center study to assess the safety, pharmacokinetics, and the preliminary antitumor activity of AZD4635 both as monotherapy and in combination in patients with advanced solid malignancies: results from prostate cancer patients, Poster Session - Genitourinary Cancer - Prostate, Testicular, and Penile, Final overall survival results from SOLO2: a Phase III trial assessing maintenance olaparib in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation, Oral Abstract Session - Gynecologic Cancer, Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study, Cediranib in combination with olaparib in patients without a germline BRCA1/2 mutation with recurrent platinum-resistant ovarian cancer: Phase IIb CONCERTO trial, Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated platinum-sensitive relapsed ovarian cancer patients: Phase IIIb OPINION interim analysis, A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer, Real-world clinical effectiveness and safety of olaparib monotherapy in HER2-negative gBRCA-mutated metastatic breast cancer: Phase IIIb LUCY interim analysis, Poster Session - Breast Cancer - Metastatic, Osimertinib as adjuvant therapy in patients with Stage IB–IIIA EGFRm NSCLC after complete tumor resection: ADAURA, Plenary Session Important notice for users
.
Winx Club Bloom And Valtor Love Fanfiction, Amazon 10 Off, Diabetic Baked Beans, Dear Evan Hansen Only Us, Allianz Health Insurance Thailand, Trinity Western University Login, Fun Employee Engagement Activities During Lockdown, How Much Money Does Joy Behar Make On The View, Thomas Aquinas College Mission Statement, André Calantzopoulos Linkedin, Lakehead University Calendar 2019-2020, Ortho Strong Capsules Uses, Limelight Club Address, Ladies Cotton T-shirts, Super Lawyers Directory, Lifeline Deutsch, Ransom Juice Wrld Lyrics, Dolly The Sheep Death, Federal Member For Lindsay, Serafina Character, Faust: Love Of The Damned Claire, Coding Story Book, Uttar Banga Krishi Viswavidyalaya, St Joseph Mn Zip Code, Article On Goal Setting, Doctor Who Youtube Full Episodes, St Mary's General Hospital Nj Leadership, The Afl Store, Mamma Mia - Take A Chance On Me, Barbican Theatre Capacity, Baillie Gifford & Co Shareholders, Old Seattle Arena, Novartis Application, Hays County Volunteer Deputy Registrar, Kraftwerk Computer Love, Guardian Angel Images Black And White, Commission Scolaire Des Trois-lacs Taxes, Square D Distributor, Winx Club Nickelodeon Episodes, Miami Ink Intro, Why Do Covalent Compounds Have Low Melting Points, New Champlain Bridge Open Today, Rôle De Taxation, Tartan Tracksuit Uk, National Pinto Bean Day, Smith And Nephew Knee Implant Price, The Outsiders Negative Book Review, Mishael Meaning, Van Morrison Poetic Champions Compose Songs, John Bishop Vegan, Dante Mask Inferno, B&b For Sale Daylesford, Orange County Housing Authority, Johnson And Johnson Competitor Analysis Essay, In Home Chef Services Near Me, List Of Private Hospitals In United Kingdom, Icy Meaning, Taming The Tiger Trauma, Palladium Group In Periodic Table, Pep Dividend, Chelsea And Westminster Maternity Reviews, On The Rocks (2020 Where To Watch), Bgsu Departments, Guilford County College Jobs, How Old Is Lovely Peaches Kid Cora, Delft University Of Technology Master's, Diploma Of Health Science Melbourne, Dallas Morning News Voter Recommendations, Curtin University Singapore Review, Moose Jaw Warriors Box Office, Valleylab Force 10, Neutrogena Deep Clean Cream Cleanser Uk, Cp All Contact Number, Ab Inbev Salary, Goal Setting Theory Quizlet, The Stella Show Youtube Parents, Eustachian Tube Balloon Dilation Success Stories, Linux Operating System That Means Humanity In Certain African Languages, Portland Hospital Maternity Reviews, Falsettos Tour 2020, Elíseo In English, Bei-ing Wanton Noodles Menu, Gerard Butler And Morgan Brown Latest News, Portail Cspo, Map Of Ipswich Hospital Wards, Jack Dee Richmond, Hurt Village Characters, Robert Schwartzman Net Worth, Reunion Tim Winton, Business Administration Job Description, Dr Fleet Cardiologist, Musa Winx Club Costume, Western Bba, Computer Coding Classes Near Me, Minimed 670g Cost,